This study is a prospective, randomized, multi-center, global investigation to determine if left atrial appendage closure with the WATCHMAN FLX Device is a reasonable alternative to oral anticoagulation in patients after AF ablation.
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Medical Center of the Rockies
Protocol Number: 20-6502
More information available at ClinicalTrials.gov: NCT03795298
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers